Invasive procedures can make dental appointments intimidating and uncomfortable for patients, impacting their experience. Minimally invasive techniques can instead preserve the trusting relationship between practitioner and patient.
For detecting the risk of oral cancer in patients, the BeVigilant™ OraFusion™ System from Vigilant Biosciences® is designed to be as minimally invasive as possible. The innovative system uses a saliva test to detect the biomarkers associated with oral cancer in a patient.
Easy to use and simple for the patient to understand too, the system provides results in 15 minutes or less, allowing for a swift procedure that will reduce the nervous waiting time that patients may have. The speed and simplicity ensure that the practitioner and patient can appropriately act on what do to next, depending on the reported risk from the system.
To promote a comfortable experience for patients, consider the effective BeVigilant™ OraFusion™ System today and be one step ahead of oral cancer.
For more information, visit www.vigilantbiosciences.com or email info@vigilantbiosciences.com
